Shareholder Alert: Ademi LLP investigates whether Meridian Bioscience, Inc. has obtained a Fair Price in its transaction with the Consortium

Provided By PR Newswire

Last update: Jul 7, 2022

MILWAUKEE, July 7, 2022 /PRNewswire/ -- Ademi LLP is investigating Meridian (NASDAQ: VIVO) for possible breaches of fiduciary duty and other violations of law in its transaction with the Consortium.